Who is the CEO of BASKHANBIOPharma?

According to the DART company overview, BASKHANBIOPharma's representative director is 이법표 (name as registered in Korean). The company was founded on 1986-03-25.

Where is BASKHANBIOPharma listed?

BASKHANBIOPharma trades on the Korea Exchange KONEX market under the ticker 354390. Its fiscal year ends in December.

Does BASKHANBIOPharma pay a dividend?

BASKHANBIOPharma did not pay a cash dividend for fiscal 2025, according to its annual report.

Which companies are in the same industry as BASKHANBIOPharma?

Under the Korean Standard Industrial Classification recorded on DART, BASKHANBIOPharma is grouped with 107 other listed companies in pharmaceuticals. The most covered in Korean news over the past 30 days are Hanmi Pharm, Yuhan and Daewoong Pharma.

BASKHANBIOPharma KRX:354390KONEX

바스칸바이오제약 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days0

Articles tracked0since Sep 11

BASKHANBIOPharma (바스칸바이오제약) appeared in 0 Korean news articles and 0 DART filings over the past seven days.

BASKHANBIOPharma top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest BASKHANBIOPharma news Korean headlines

No articles yet.

Articles per day 2 weeks

Company profile

CEO: 이법표
Industry: Pharmaceuticals
Founded: 1986-03-25
Fiscal year-end: December
Head office: 경기도 안성시
Website: baskhanbio.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Same industry Pharmaceuticals

All in industry

Company	Latest quarter op. profit	Articles 30d
Hanmi Pharm	₩131bn	656
Yuhan	₩66.9bn	492
Daewoong Pharma	₩68.1bn	376
GC Biopharma	₩1.7bn	330
DongKookPharmaceutical	₩26.1bn	256
Daewon Pharmaceutical	−₩9m	201
Kwangdong Pharmaceutical	₩2.8bn	187
JW Pharmaceutical	₩33.3bn	185

Compare BASKHANBIOPharma side by side with these companies

BASKHANBIOPharma DART filings

Sep 2816:40

Other 지정자문인선임계약의변경
Other

Mentioned alongside 2 weeks

No co-mentioned companies yet.

BASKHANBIOPharma FAQ

Who is the CEO of BASKHANBIOPharma?: According to the DART company overview, BASKHANBIOPharma's representative director is 이법표 (name as registered in Korean). The company was founded on 1986-03-25.
Where is BASKHANBIOPharma listed?: BASKHANBIOPharma trades on the Korea Exchange KONEX market under the ticker 354390. Its fiscal year ends in December.
Does BASKHANBIOPharma pay a dividend?: BASKHANBIOPharma did not pay a cash dividend for fiscal 2025, according to its annual report.
Which companies are in the same industry as BASKHANBIOPharma?: Under the Korean Standard Industrial Classification recorded on DART, BASKHANBIOPharma is grouped with 107 other listed companies in pharmaceuticals. The most covered in Korean news over the past 30 days are Hanmi Pharm, Yuhan and Daewoong Pharma.